Physician profile
Sunil Patel
NPI 1699809806
$1,255.24
in general payments reported to CMS, 2019-2025
18 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.03 · 2020: $117 · 2021: $60.43 · 2022: $248 · 2023: $147 · 2024: $297 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.68 | 2019-2025 | |
| Madrigal Pharmaceuticals | $144.35 | 2025 | Rezdiffra |
| Fujifilm Healthcare Americas Corporation | $133.63 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $112.60 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.05 | 2019-2023 | Entyvio |
| Gilead Sciences, INC. | $48.55 | 2019-2022 | |
| Medtronic, INC. | $35.07 | 2025 | Nexpowder |
| Janssen Biotech, INC. | $26.90 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $26.04 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.67 | 2019 | |
| Amgen INC. | $23.35 | 2022 | |
| Boston Scientific Corporation | $22.50 | 2025 | Avvigo Guidance System |
| Merck Sharp & Dohme LLC | $20.94 | 2022 | |
| Lilly USA, LLC | $18.31 | 2024 | Omvoh |
| Pfizer INC. | $16.70 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $15.90 | 2024 | Voquezna |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.